Related content

A pharmacological profile of the selective silent 5-HT 1A receptor antagonist, WAY-100635

By Forster E.A.   Cliffe I.A.   Bill D.J.   Dover G.M.   Jones D.   Reilly Y.   Fletcher A.  

European Journal of Pharmacology, Vol. 281, Iss. 1, 1995-07 ,pp. : 81-88

Elsevier

Access to resources Recommend Favorite

Catalepsy induced by the 5-HT 1A receptor antagonist WAY 100635 in rats pretreated with the selective serotonin reuptake inhibitor citalopram

By Eltayb A.   Svensson T.H.   Ahlenius S.  

European Journal of Pharmacology, Vol. 411, Iss. 3, 2001-01 ,pp. : 275-277

Elsevier

Access to resources Recommend Favorite

Effects of WAY 100635 and (-)-5-Me-8-OH-DPAT, a novel 5-HT 1A receptor antagonist, on 8-OH-DPAT responses

By Trillat A.-C.   Malagie I.   Mathe-Allainmat M.   Anmela M.-C.   Jacquot C.   Langlois M.   Gardier A.M.  

European Journal of Pharmacology, Vol. 347, Iss. 1, 1998-04 ,pp. : 41-49

Elsevier

Access to resources Recommend Favorite

Synergistic actions of the 5-HT 1A receptor antagonist WAY-100635 and citalopram on male rat ejaculatory behavior

By Ahlenius S.   Larsson K.  

European Journal of Pharmacology, Vol. 379, Iss. 1, 1999-08 ,pp. : 1-6

Elsevier

Access to resources Recommend Favorite

Involvement of 5HT1A receptors in the anxiolytic-like effects of cannabidiol injected into the dorsolateral periaqueductal gray of rats

By Campos Alline   Guimarães Francisco  

Psychopharmacology, Vol. 199, Iss. 2, 2008-08 ,pp. : 223-230

Springer Publishing Company

Access to resources Recommend Favorite